Heat Biologics (HTBX) Posts Q2 Loss of 44c/Share

Heat Biologics (NASDAQ: HTBX) reported Q2 EPS of ($0.44), $0.04 worse than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Heat Biologics (HTBX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c